DOI QR코드

DOI QR Code

Patent Infringement under Japanese Patent law: Comparative Study with Chinese Patent Law

  • Cai, Wanli (Institute of Liberal Arts and Science, Toyohashi University of Technology)
  • Received : 2018.11.13
  • Accepted : 2018.12.17
  • Published : 2018.12.31

Abstract

Patent infringement is defined as implementing a whole patent product without authorization, which is called literal infringement. However, the alleged infringer sometimes does not directly produce the same product with the patented invention, but they simply replace some claimed elements with new materials, or they only produce a certain part of the patent product. Therefore, there is an issue on whether the above cases should also be deemed as patent infringement. This paper uses specific cases to analyze the formation and development process of the doctrine of equivalents and indirect infringement theory in Japan. Then, by discussing the interpretation of Article 101 of the current Japanese patent law, this paper makes it clear that whether it constitutes direct or indirect infringement in some particular cases. The objective of this paper is to clarify the specific requirements of patent infringement under Japanese patent law by case studying and comparing with the patent legal system of China.

Keywords

GSHSS5_2018_v7n3_606_f0001.png 이미지

Figure 1 The scope of patent right

GSHSS5_2018_v7n3_606_f0002.png 이미지

Figure 2 Cases of infringement and non-infringement

GSHSS5_2018_v7n3_606_f0003.png 이미지

Figure 3 Doctrine of equivalents

GSHSS5_2018_v7n3_606_f0004.png 이미지

Figure 4 Objective indirect infringement

GSHSS5_2018_v7n3_606_f0005.png 이미지

Figure 5 The limitation of objective indirect infringement

GSHSS5_2018_v7n3_606_f0006.png 이미지

Figure 6 Subjective indirect infringement

GSHSS5_2018_v7n3_606_f0007.png 이미지

Figure 7 A fueling device invention

GSHSS5_2018_v7n3_606_f0008.png 이미지

Figure 8 Case 3

GSHSS5_2018_v7n3_606_f0009.png 이미지

Figure 9 An invention of combined drug of pioglitazone

GSHSS5_2018_v7n3_606_f0010.png 이미지

Figure 10 The major generic pharmaceutical company and the small generic manufacturer

References

  1. Chinese Patent Law (2008) Article 59.
  2. Chinese Patent Law Amendment (4th Draft), Article 62.
  3. Chinese Judicial Interpretation: Several Provisions of the Supreme People's Court on Issues Concerning Applicable Laws to the Trial of Patent Controversies (No.21 (2001)), Article 17.
  4. Issues Concerning Applicable Laws to the Trial of Patent Controversies (No.21 (2001)), Article 17.
  5. Court of Japan Showa 50 (WA) 9647, Tokyo District Court, Http://www.courts.go.jp/app/files/hanrei_jp/235/014235_hanrei.pdf.
  6. Court of Japan. Heisei 23 (WA) 19435, Tokyo District Court, Http://www.courts.go.jp/app/files/hanrei_jp/042/083042_hanrei.pdf.
  7. Court of Japan Heisei 6 (O) 1083, The Supreme Court, Http://www.courts.go.jp/app/files/hanrei_jp/790/052790_hanrei.pdf.
  8. Japanese Patent Law, Article 29.
  9. Japanese Patent Law, Article 68, 70, 101.
  10. Japan Patent Office (2007) Patent Infringement litigation in Japan, Http://quon-ip.jp/30e/Patent%20Infringement%20Litigation%20in%20Japan.pdf.
  11. Martin, A. (2011) Global Issues in Patent Law, West, 207-214.
  12. Takabayashi, R. (2014) Patent Law, Yuhikaku, 166-171.
  13. Tamura, Y. (2009) The Theory of Patent Law, Yuhikaku, 169-179.